#US Benign Prostatic Hyperplasia Procedures Market Growth

[global-research-report]

From Wearables to Surgery: Innovations in Male Incontinence Care

The global male urinary incontinence market size is anticipated to reach USD 10.02 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.87% from 2023 to 2030. Rapid advancements in technology, an increasing demand for minimally invasive procedures, rising healthcare expenditure, and advancements in non-absorbent & absorbent products drive industry growth. Also, the increasing prevalence of chronic diseases is anticipated to expand the market for male urinary incontinence globally.

One of the key factors driving market expansion is the rapid technical advancements linked to incontinence. Synthetic MS for Proton Pump Inhibitors (PPI) has risen in popularity in recent years since it is less expensive, less intrusive, and does not require mechanical manipulation during voiding. For example, the innovation of fit and efficient pouching systems and associated accessories to improve patient’s quality of life is projected to drive the market.

Boston Scientific Corporation, Coloplast Corp., and Teleflex Incorporated are a few of the key players in the market that are investing significantly in research and development activities to introduce new products. For instance, Coloplast Corp. launched its innovative male catheter Luja in February 2023, making it the first and only male catheter with over 80 micro-holes designed to address the primary urinary tract infection risk factor linked with intermittent catheterization.

Despite its potential for expansion, the male urinary incontinence industry faces obstacles such as a lack of knowledge and inconsistent reimbursement rules. Technological developments, better patient education, and continuous research, on the other hand, are projected to stimulate the development of more effective and less intrusive treatment alternatives. Furthermore, the combination of digital health solutions and telemedicine may help improve access to diagnosis and treatment for males with urine incontinence.

Male Urinary Incontinence Market Report Highlights

In 2022, the absorbents product segment dominated the male urinary incontinence industry with a revenue share of 70.60%. The market for absorbent devices has experienced several technological and design developments, with the goal of providing consumers with improved ease of use and reliability

Based on incontinence type, the urge urinary incontinence segment held the dominant revenue share of around 57.18 % in 2022, owing to the increasing incidences of age-related illnesses such as prostate problems, which may cause prostate issues such as benign prostatic hyperplasia or prostate cancer that can lead to bladder discomfort and, as a result, urgent urine incontinence

In terms of usage, the disposable segment held the largest market share of around 68.93% in 2022. Disposable products are very easy to use, as they allow users to conveniently dispose of used products and replace them with new ones

With regard to distribution channels, the offline store segment held the largest market share of 54.26% in 2022. Local customers who prefer to purchase these products in person rather than waiting for their online delivery benefit from offline facilities

Among end-users, hospitals held a majority share of 64.77% of the market in 2022. Hospitals are critical in educating patients about urine incontinence, its causes, and treatment choices.In addition, in severe cases of urine incontinence, hospitals may offer surgical therapies such as sling surgery, artificial urinary sphincter implantation, and others

Europe dominated the global market for male urinary incontinence with a revenue share of 49.81% in 2022. Growing demand for minimally invasive surgeries, along with rising government initiatives for improving the healthcare infrastructure, are among the key factors driving regional market growth. In addition, technological advancements and innovation of new non-invasive techniques will create lucrative opportunities for the segment in the coming years

Curious about the Male Urinary Incontinence Market? Get a FREE sample copy of the full report and gain valuable insights.

Male Urinary Incontinence Market Segmentation

Grand View Research has segmented the global male urinary incontinence market on the basis of product, incontinence type, usage, distribution channel, end-use, and region:

Male Urinary Incontinence Product Outlook (Revenue, USD Million, 2018 - 2030)

Non-Absorbents

Urinary Catheters

Foley Catheters

External Catheters

Drainage Bags

External Compression Devices/Penile Clamps

Artificial Urinary Sphincter

Others

Absorbents

Underwear & Briefs

Drip Collectors & Bed Protectors

Pads & Guards

Male Urinary Incontinence Type Outlook (Revenue, USD Million, 2018 - 2030)

Stress Urinary Incontinence

Urge Urinary Incontinence

Overflow Incontinence

Functional Urinary Incontinence

Mixed Urinary Incontinence

Male Urinary Incontinence Usage Outlook (Revenue, USD Million, 2018 - 2030)

Reusable

Disposable

Male Urinary Incontinence Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Offline Stores

Online Channels

Male Urinary Incontinence End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals & Clinics

Homecare

Others

Male Urinary Incontinence Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Norway

Denmark

Sweden

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Key Players in the Male Urinary Incontinence Market

Essity

Kimberly-Clark Worldwide Inc.

Attends Healthcare Products, Inc.

ABENA

Coloplast Corp.

Teleflex Incorporated

Boston Scientific Corporation

Ontex Healthcare

PAUL HARTMANN AG

First Quality

Medline

BD

Hollister Incorporated

Cardinal Health

Order a free sample PDF of the Male Urinary Incontinence Market Intelligence Study, published by Grand View Research.

[healthcaremarketanalysis]

Urology Devices Industry worth $48.6 billion by 2028

 The global urology devices market, valued at US$32.6 billion in 2022, is forecasted to grow at a robust CAGR of 7.3%, reaching US$34.1 billion in 2023 and an impressive US$48.6 billion by 2028. Investments by hospitals in procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices. Moreover, increased demand for MIS robotic systems is expected to increase in the coming years, which is expected to propel the market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212

Browse in-depth TOC on “Urology Devices Market”

159 — Tables

44 — Figures

274 — Pages

In 2022, the instruments segment held the largest share of the urology devices market by product segment.

The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022. This segment covers the most commonly used products, such as dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, robotic systems, insufflators, endoscopy fluid management systems, urodynamic systems and other instruments. These products are commonly used in hospitals, dialysis centers and home care settings. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to the urological procedures.

The kidney diseases segment held the largest share of the urology devices market by application segment in 2022.

The global urology devices market is differentiated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. In 2022, the kidney diseases segment dominated the urology devices market. The urology devices market in kidney diseases is expected to grow at a high rate owing to the rising incidence of kidney diseases and chronic diseases. With a burgeoning global population, the need for urology devices has significantly increased due to the increased number of procedures required. Hospitals and dialysis centers are at the forefront of this surge, as they cater to routine medical care and handle emergencies.

The hospitals, ASCA & clinics segment held the largest share of the urology devices market by end-user segment in 2022.

The global urology devices market is differentiated into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment dominated the urology devices market. The urology devices market in hospitals is expected to grow at a high rate owing to the increasing number of surgical procedures related to urology care. The expanding network of healthcare institutions directly translates to a substantial market share, reflecting the pivotal role hospitals play in safeguarding patient well-being.

North America is the largest regional market for urology devices market.

The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region’s advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173062212

Urology Devices Market Dynamics:

Drivers:

1. Rising incidence of urological diseases

2. Growing preference for minimally invasive procedures

3. Rising focus on R&D and product launches

4. Growing number of hospitals and surgical centers

Restraints:

1. High degree of consolidation among key players

Opportunities:

1. Growing Potential growth opportunities in emerging economies

2. Technological advancements

Challenge:

1. Increasing number of product recalls by key players

2. Shortage of skilled urologists

Key Market Players of Urology Devices Industry:

The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).

The break-up of the profile of primary participants in the urology devices market:

By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3–30%

By Designation: C-level — 27%, D-level — 18%, and Others — 55%

By Region: North America — 51%, Europe — 21%, Asia Pacific — 18%, Latin America — 6%, and Middle East & Africa- 4%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173062212

[metatechinsights]

Urinary Catheters Market Size and Forecast 2025-2035

The urinary catheters market is experiencing steady growth, with an expected market size of USD 2.3 billion in 2024, projected to reach USD 3.5 billion by 2035, growing at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2035. Urinary catheters are medical devices used for draining urine from the bladder when a patient is unable to do so naturally. The increasing prevalence of conditions such as urinary incontinence, bladder dysfunction, and post-surgical recovery is driving the demand for urinary catheters across the globe.

Market Drivers

Rising Prevalence of Urinary Disorders One of the primary factors driving the growth of the urinary catheters market is the rising prevalence of urinary disorders, including urinary retention, incontinence, and benign prostatic hyperplasia (BPH). These conditions are more common in the elderly population, leading to a growing need for catheterization in healthcare settings.

Technological Advancements in Catheter Design Advances in catheter technology, such as the development of antimicrobial-coated catheters, have helped reduce complications like urinary tract infections (UTIs), one of the major risks associated with catheterization. Manufacturers are also focusing on enhancing the comfort and safety of the devices, which is expanding their usage.

For more detailed insights and market trends, explore the full report here.

Increase in Surgical Procedures The growing number of surgical procedures worldwide is another key driver for the urinary catheter market. Post-surgical patients often require urinary catheters for short-term or long-term use, particularly those who have undergone surgeries affecting the pelvic region or urinary tract.

Rise in Geriatric Population The aging global population is a significant contributor to the market growth. Older individuals are more likely to experience conditions like incontinence and mobility issues, leading to an increased need for urinary catheters. The geriatric demographic is expected to drive the demand for both short-term and long-term catheterization solutions.

Regional Insights

North America: Dominates the urinary catheters market due to advanced healthcare systems, high awareness levels, and the rising incidence of chronic diseases.

Europe: Follows closely, with increasing healthcare spending and the growing elderly population contributing to market growth.

Asia Pacific: Expected to grow at the highest rate, driven by the rising healthcare infrastructure and awareness of medical devices.

Challenges and Opportunities Although the market is growing, challenges such as catheter-associated urinary tract infections (CAUTIs) and high treatment costs remain. However, opportunities lie in the development of next-generation catheters and expanding healthcare access in emerging economies.

In conclusion, the urinary catheters market is poised for growth, driven by technological advancements, increasing surgical procedures, and the aging population. Innovations in catheter design and expanding healthcare access will further fuel market expansion.

[poonamcmi]

Cyproterone Acetate Market Poised to Grow at a Robust Pace due to Rising Demand for Anti-Androgens

The cyproterone acetate market has witnessed rising demand over the years owing to increasing applications of cyproterone acetate as a powerful anti-androgen. Cyproterone acetate is an anti-androgen steroidal drug that is used for the treatment of hypersexuality or hypersexual disorder, enlarged prostate or benign prostatic hypertrophy, and hirsutism or excessive hair growth in women. It acts by competitively inhibiting androgens like testosterone and dihydrotestosterone from binding to androgen receptors in target tissues.

The Global cyproterone acetate market is estimated to be valued at US$ 327.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the cyproterone acetate market are Curia, Axplora, LGM Pharma, Hubei Gedian Humanwell Pharmaceutical, Cipla, NEWCHEM SPA, Swati Spentose, Teva API, Teva Pharmaceutical Industries, Unipex, Zhejiang Xianju Pharmaceutical Co. Ltd, KRKA, Cambrex, Sicor De México, Zhejiang Xianju Xianle, Shaoxing Hantai Pharma, and Farmabios. The key players are engaged in developing improved formulations and delivery methods of cyproterone acetate to increase market share.

The rising prevalence of hormonal disorders like hypersexuality, hirsutism and benign prostatic hyperplasia has opened up opportunities for pharmaceutical manufacturers in the Cyproterone Acetate Market Size Furthermore, increasing awareness about treatment options and availability of generic drugs are fueling the demand.

Technological advancements in drug delivery systems like transdermal patches, gels, and nano-formulations are allowing for better management of hormonal disorders and can drive the adoption of cyproterone acetate.

Market Drivers

A key driver for the cyproterone acetate market is the rising geriatric population who are more prone to benign prostatic hyperplasia. Furthermore, changing lifestyles and increasing stress levels have contributed to the rise in disorders like hypersexuality which is also propelling the demand. Favorable government policies for generic drugs and availability of generic versions of cyproterone acetate at lower costs are facilitating greater market penetration. Challenges in Cyproterone Acetate Market:

Patent Expiry of Acetate Products. Cyproterone Acetate Market  Size And Trends drugs are widely used in the treatment of sex hormone-dependent disorders like precocious puberty, hirsutism and acne, however many patented drugs containing cyproterone acetate are going off patent in the coming years leading to increased competition in the generic market.

Stringent Regulatory Guidelines: Approval processes for new drugs and formulations containing cyproterone acetate are long and stringent. Regulatory authorities like USFDA and EMA impose rigorous evaluation procedures to ensure safety and efficacy. This increases clinical trial timelines and costs.

Potential Side Effects: Cyproterone acetate has few potential side effects if taken for a long duration. Side effects reported include nausea, vomiting, headache, breast tenderness or swelling. Rare side effects include hepatitis, changes in liver function values and blood clotting problems. Potential risks require monitoring and further research on safety.

SWOT Analysis:

Strengths: High growth opportunities in generic drugs market. Well established uses in treatment of hormonal disorders. Weaknesses: Patents expiry of branded drugs. Potential side effects require further safety evaluation. Opportunities: Developing novel drug delivery systems to reduce side effects. Approval of new treatment indications will boost growth. Threats: Stringent regulations delay market approvals. Intense competition from existing and emerging players.

Geographical Regions:

Currently North America accounts for the largest share in cyproterone acetate market, mainly driven by high treatment rates for hormonal disorders. Emergence of new generics and strong reimbursement structure also supports growth. Europe follows North America and holds significant revenue share due to rising healthcare expenditures.

Fastest Growing Region: Asia Pacific region is poised to be the fastest growing market for cyproterone acetate. Increasing patient pool suffering from hormonal imbalance, rising medical tourism, growing healthcare infrastructure and entry of low-cost generics will drive robust growth in Asia Pacific during forecast period. India and China will be the key revenue generators in this region.

Current challenges in Cyproterone Acetate Industry: The cyproterone acetate industry faces challenges from generic competition as major patents expire. Several drugs containing cyproterone acetate as active ingredient lost exclusivity in last few years leading to availability of low-cost generics. This has significantly reduced prices of branded formulations impacting revenues of innovator companies. Another challenge is the stringent regulatory norms for approval of new drugs. The regulatory processes have become complex over time warranting extensive clinical data and trials increasing costs and timelines for industry players. Potential side effects also require further evaluation on long term safety profile through ongoing clinical research. High development costs and regulatory hurdles restrict entry of new market entrants. Overall, generic competition and regulatory challenges are major pain points for cyproterone acetate industry currently. Get More Insights On, Cyproterone Acetate Market For More Insights Discover the Report In language that Resonates with you

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191

[bhushans]

Beyond Diagnosis: Exploring Urology Lasers Market

The Urology Lasers Market is experiencing rapid expansion within the medical industry, driven by cutting-edge laser technologies designed for treating urological conditions. This market's remarkable growth can be attributed to advancements in technology, the integration of telemedicine solutions, and the growing popularity of minimally invasive procedures. These transformative innovations are reshaping urological care, leading to improved precision, better patient outcomes, and increased accessibility to specialized consultations. As the industry continues to evolve, the potential for further advancements promises to revolutionize urology treatments and elevate patient care to new heights.

The market for urology lasers is expected to reach US$ 2.6 Billion in 2033, up from US$ 1.1 Billion in 2023, with a 9.0% CAGR from 2023 to 2033. The global urology lasers market is expected to grow significantly, owing to an increase in the prevalence of urology disorders worldwide and a growing preference for non-invasive surgical procedures.

The urology lasers market is experiencing a significant surge, fueled by remarkable technological advancements and the increasing integration of telemedicine solutions.

These pioneering progressions are revolutionizing the field by enhancing precision, improving patient outcomes, and enabling remote consultations and monitoring.

The market is witnessing a dynamic shift as urologists embrace innovative laser technologies and leverage telemedicine platforms, resulting in improved access to care, streamlined workflows, and expanded treatment options for urological conditions.

The combination of cutting-edge innovations and the growing adoption of telemedicine solutions are propelling the urology lasers market to new heights of growth and transforming the landscape of urological care.

Download The Free Sample PDF https://www.futuremarketinsights.com/reports/sample/rep-gb-17766

Advancements in laser technology have played a pivotal role in transforming urological surgeries. Laser systems offer improved precision, allowing surgeons to target specific tissues and minimize damage to surrounding areas.

The integration of advanced imaging modalities, such as ultrasound and fluoroscopy, further enhances accuracy and enables real-time visualization during procedures.

Laser devices have found applications in multiple urological procedures, including the treatment of kidney stones, benign prostatic hyperplasia (BPH), bladder tumors, and urethral strictures.

The ability to perform minimally invasive surgeries with urology lasers has reduced hospital stays, faster recovery times, and improved patient outcomes. Patients can now benefit from less post-operative pain, minimal scarring, and a quicker return to normal activities.

The urology lasers market is poised for significant growth in the coming years, driven by technological advancements, the rise of minimally invasive surgeries, the increasing prevalence of urological disorders, and the integration of telemedicine solutions.

Key market players are actively investing in research and development activities to enhance the capabilities of urology lasers further and expand their applications. However, challenges such as the high costs of urology laser devices and procedures, safety concerns, and a lack of awareness about laser treatments still need to be addressed.

Collaborations between industry stakeholders, regulatory bodies, and healthcare professionals play a crucial role in overcoming these challenges and unlocking the market's full potential.

Key Takeaways From the Urology Lasers Market:

China is likely to exhibit a CAGR of 8.9% in the urology lasers industry, showcasing strong growth potential.

The market in the United States of America demonstrates robust growth with a CAGR of 9.0% from 2023 to 2033.

The United Kingdom's urology lasers industry is projected to secure a steady CAGR of 8.7% during the projected period.

The benign prostatic hyperplasia segment is likely to secure an 8.8% growth rate from 2023 to 2033.

The holmium laser-type segment is expected to be at the forefront of the market with an 8.9% CAGR from 2023 to 2033.

Top Competition Landscape in the Urology Lasers Industry:

The competition landscape in the urology lasers industry is characterized by intense rivalry among key market players.

Boston Scientific Corporation

Cook Medical Incorporated

Healthtronics, Inc.

Jena Surgical GmbH

Karl Storz GmbH & Co.Kg

Several prominent companies actively engage in research and development activities to introduce innovative urology laser devices and expand their product portfolios.

Strategic collaborations, mergers, and acquisitions are common strategies employed to gain a competitive edge. Furthermore, companies focus on enhancing their market presence through extensive marketing and promotional activities.

With a growing demand for urology lasers, market players strive to establish strong distribution networks, foster partnerships with healthcare facilities, and provide comprehensive customer support and training programs.

Recent Developments in the Urology Lasers Market:

Miniaturization of Laser Devices: Manufacturers have made significant strides in miniaturizing urology lasers, allowing for less invasive procedures and improved patient comfort. The development of compact and portable laser devices has enabled healthcare professionals to perform precise treatments with greater maneuverability.

Advancements in Laser Fiber Technology: Recent innovations in laser fiber technology have led to the development of more efficient and durable fibers. These improved fibers deliver higher energy levels, resulting in enhanced tissue ablation capabilities and reduced procedure times.

Integration of Robotics and AI: The integration of robotics and artificial intelligence (AI) into urology lasers has revolutionized surgical precision and automation. Robotic-assisted laser procedures offer superior accuracy and enable surgeons to perform complex operations with enhanced control and minimal invasiveness.

Telemedicine Solutions: The rise of telemedicine platforms has facilitated remote consultations, preoperative assessments, and postoperative follow-ups. Telemedicine solutions have expanded access to urology specialists and allowed patients in remote areas to receive expert guidance and care.

Segmentation Analysis Of Urology Lasers Market:

By Laser Type:

Holmium

Thulium

Diode

Others

By Application:

Benign Prostatic Hyperplasia

Urolithiasis

Non-Muscle Invasive Bladder Cancer (NMIBC)

Others

Urology Laser Market

[mrfr-blogs]

Navigating the Dynamics of Urology Devices Market Industry

Market Overview –

The Urology Devices Market encompasses medical devices and equipment used in the diagnosis, treatment, and management of urological disorders and conditions affecting the urinary tract and male reproductive system. This includes devices for urinary incontinence, kidney stones, benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), erectile dysfunction, and other urological conditions.

One significant driver of the Urology Devices Market's growth is the increasing prevalence of urological disorders worldwide, driven by factors such as aging demographics, lifestyle changes, and the rising incidence of chronic diseases such as diabetes and hypertension. As the population ages, the demand for urology devices for conditions such as urinary incontinence, BPH, and kidney stones is expected to rise.

Advancements in urological procedures and minimally invasive surgical techniques have also fueled market growth by expanding the scope of treatment options available to patients. Urology devices such as catheters, stents, lithotripters, and robotic surgical systems enable healthcare providers to perform complex procedures with greater precision, reduced recovery times, and improved patient outcomes.

Moreover, the increasing awareness of urological health and the availability of advanced diagnostic and treatment options have led to greater patient demand for urology devices and services. As healthcare systems prioritize preventive care and early intervention, the Urology Devices Market is expected to continue growing, offering opportunities for innovation and investment in medical device technology.

The Urology Devices Market is witnessing steady growth, driven by rising urological disorders and technological advancements in medical devices. Urology devices such as catheters, stents, and endoscopes are vital in diagnosing and treating urinary tract conditions. With a growing aging population and increasing awareness, the demand for urology devices continues to escalate.

The urological devices market was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.

Market Segmentation –

The global Urology Devices market has been segmented based on Type, Application, Technology and End-User.

On the basis of Type, the market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, and urinary incontinence & pelvic organ prolapse. The market revenue for urology devices was dominated by endoscopic devices in 2022, which can be ascribed to the rising prevalence of urolithiasis and the strong demand for disposable cystoscopes, particularly in developed nations.

Based on Application, the global Urology Devices market has been segmented into Minimally Invasive Surgery and Robotic Surgery. In 2022, the minimally invasive surgery category dominated the industry. According to projections, the terminal side segment will experience the largest growth between 2023 and 2030, with an increase in urological problem patients choosing minimally invasive procedures over more invasive ones.

Based on Technology, the global Urology Devices market has been segmented into benign prostatic hyperplasia, prostate cancer, urinary stones, and urinary incontinence. Due to the higher risk of developing urine incontinence in diabetic patients, the urinary incontinence Urology Devices category had the majority share of the market revenue for Urology Devices in 2022.

Based on End-User, the global Urology Devices market has been segmented into hospitals and ambulatory services. Due to the increasing number of patient visits at hospitals for urology-related illnesses, the hospitals and clinics segment, which held the market's top spot in 2022, is anticipated to grow at the fastest rate throughout the forecast period, 2023-2030.

Regional Analysis –

The regional analysis of the urology devices market reveals varying dynamics influenced by factors such as healthcare infrastructure development, prevalence of urological disorders, and regulatory frameworks. North America dominates the market, driven by the high prevalence of conditions like urinary incontinence and kidney stones, coupled with advanced medical technology adoption. Europe follows suit, with increasing investments in urology devices and rising demand for minimally invasive procedures. In the Asia-Pacific region, improving access to healthcare services, growing aging population, and increasing awareness about urological health contribute to market growth. Developing regions in Latin America and Africa are also witnessing gradual market expansion as healthcare infrastructure improves and awareness about urological disorders increases.

Key Players –

Urology devices companies include KARL STORZ GmbH & Co. KG, Olympus Corporation, Medtronic, Boston Scientific Corporation, R. Bard, Fresenius Medical Care AG & Co. KGaA (Germany), Dornier MedTech (Germany), and Stryker (US)

Related Reports –

US Melanoma

Middle East and Africa HIV Diagnosis & Treatment

Gastroparesis Treatment

Dental Infection Treatment

For more information visit at MarketResearchFuture

[blog-site-for-market-research]

Urology Devices Market Size, Share, Trends, and Growth Opportunity Analysis

Market Scope

The urology devices market size was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.

Growth Drivers and Challenges

Notable rise in the number of patients suffering from diabetes and high blood pressure (hypertension) has fostered the demand for advanced urology devices in recent years. These diseases are known for causing kidney failure. The American Kidney Fund’s recent studies show that nearly 40.4% of the overall kidney failure cases worldwide are caused by diabetes, while 30% is the result of high blood pressure. Cases of diabetes and hypertension have been surging exponentially in developing countries across Middle East and Asia Pacific, considering the prevalence of stressful and hectic lifestyle and the burgeoning elderly populace.

Another growth rendering factor can be the expanding geriatric population prone to kidney and urinary disorders. The demand for urology devices is further elevated by the mounting demand for minimally invasive procedures and surge in technical advances. Canada as well as the United States (US) are experiencing substantial rise in the number of people affected by chronic kidney and urinary disorders in conjunction with the growing prevalence of a sedentary lifestyle. On top of this, large-scale funds by governments for improving the healthcare infrastructure would also have an incredible impact on the global market.

Market Segmentation

The MRFR study has outlined various aspects of the urology devices industry for enhanced understanding, shedding light on major segments like types, applications, technology, and end users.

Different types of urology devices available in the industry are endoscopy devices, urinary incontinence & pelvic organ prolapsed devices, urinary stone treatment devices, benign prostatic hyperplasia treatment devices, dialysis equipment, and more.

Urology devices’ top applications are Prostate Cancer, Urinary Incontinence, Urinary Stones, as well as Benign Prostatic Hyperplasia. Urinary stones occur in 1 in every 20 individuals, with the major reasons being diabetes, high blood pressure, and history of kidney failure. As a result, urology devices market trends are witnessing enormous demand for treating urinary stones, cases of which have been escalating rapidly worldwide.

Technology-wise, the segments are minimally invasive surgery, robotic surgery, and more.  

End-users listed are ambulatory services, hospitals, and more.

Regional Analysis

The urology devices industry has been regionally considered for APAC/Asia Pacific, MEA/Middle East & Africa, the Americas, and Europe.

America maintains its winning streak and will continue to do so throughout the evaluation timeframe, thanks to the escalating cases of kidney stones, traumatic injury, prostate cancer, and others. The American Urological Association Foundation confirms that benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections, and kidney and ureteral stones are the top urological ailments occurring in the region. Surge in lifestyle-based health issues, significant healthcare spending, and a well-developed healthcare system present in both Canada and the US also add to the regional market value. Favorable reimbursement structure also add to the market worth. Not only clinics and hospitals, but urology devices are increasingly being used in the domestic sector as well, as the rising number of geriatric patients prefer at-home settings.

Asia Pacific could be the fastest progressing market in the next few years, on account of the booming population with significant unmet medical needs and the surge in economic standards. Mounting cases of Benign Prostatic Hyperplasia (BPH) as well as Urinary Tract Infection (UTI) also raises the demand for urology devices. With the rising focus on replacing and upgrading the existing healthcare infrastructure, urology devices would note higher demand in the following years. Besides, majority of the players in the region are spending considerably on exhaustive research and development of the latest types of urology devices. Urology device manufacturers are also indulging in mergers and acquisitions to enhance individual as well as cumulative industry growth.

Top Companies

The top urology devices manufacturers in the market are C. R. Bard Inc. (US), Boston Scientific Corporation (US), Stryker (US), Olympus Corporation (Japan), HealthTronics, Inc (US), KARL STORZ GmbH & Co. KG (Germany), NIKKISO CO. LTD (Japan), Medtronic (US), Dornier MedTech (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Cook (US), and many more.

These contenders expend huge amounts on research and development (R&D) for product innovation as well as new launches, which helps them gain a higher share in the worldwide industry. They also use strategies such as acquisitions, FDA approvals, collaborations, expansions, and joint ventures, among others.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

[techninja]

Redefining Pain Management: Radiofrequency Ablation Device Market on the Rise

Introduction

The Radiofrequency Ablation Device Market has witnessed remarkable growth in recent years due to its effectiveness in treating various medical conditions, ranging from chronic pain management to oncological interventions. Radiofrequency ablation (RFA) is a minimally invasive procedure that uses high-frequency electrical currents to heat and destroy abnormal tissues or nerves, offering patients a safer and less invasive alternative to surgery. This article explores the current landscape and emerging trends in the Radiofrequency Ablation Device Market.

Market Overview

The global Radiofrequency Ablation Device Market has been expanding steadily, driven by increasing awareness among both patients and healthcare professionals about the benefits of RFA procedures. Chronic pain management remains one of the primary applications of radiofrequency ablation, with an aging population and rising prevalence of chronic pain conditions contributing to market growth.

Key Trends in the Radiofrequency Ablation Device Market

1. Advancements in Technology: The Radiofrequency Ablation Device Market is witnessing continuous technological advancements. Manufacturers are developing innovative devices with improved precision and safety features. The integration of advanced imaging technologies like real-time ultrasound and MRI guidance has increased the accuracy of RFA procedures, making them more effective.

2. Expanding Indications: Radiofrequency ablation is no longer limited to pain management. The market is witnessing an expansion in the range of clinical indications, including the treatment of cardiac arrhythmias, liver tumors, and benign prostatic hyperplasia. This diversification of applications is opening up new opportunities for device manufacturers.

3. Growing Geriatric Population: With the global aging population, the demand for minimally invasive treatment options is on the rise. Elderly individuals are more prone to conditions such as osteoarthritis and back pain, making RFA an attractive option. This demographic shift is a significant driver of market growth.

4. Outpatient Settings: The trend toward outpatient and office-based medical procedures has accelerated due to the COVID-19 pandemic. Radiofrequency ablation, with its minimally invasive nature and reduced recovery time, fits well into this trend. More RFA procedures are now being performed outside traditional hospital settings.

5. Rising Adoption of RFA for Cancer Treatment: Radiofrequency ablation is increasingly being used as an alternative or adjunct therapy for certain types of cancer. It is particularly effective for patients who are not suitable candidates for surgery. The market is witnessing increasing interest in RFA devices for oncological applications.

6. Regulatory Advancements: Regulatory bodies are actively involved in streamlining and expediting the approval process for radiofrequency ablation devices. This is promoting innovation and ensuring that safe and effective devices reach the market faster.

7. Market Consolidation: The Radiofrequency Ablation Device Market has been witnessing consolidation as larger healthcare companies acquire smaller manufacturers. This consolidation is often aimed at expanding product portfolios and gaining a competitive edge in the market.

8. Patient-Centric Approach: Patients are becoming more proactive in their healthcare decisions. This shift towards a patient-centric approach is driving the demand for minimally invasive procedures like RFA, as patients seek treatments that offer shorter recovery times and reduced side effects.

Conclusion

The Radiofrequency Ablation Device Market is poised for continued growth in the coming years. Advancements in technology, a broader range of clinical applications, and the aging global population are among the primary factors driving this growth. As the market continues to evolve, it is expected that radiofrequency ablation will become an even more integral part of modern medical practice, offering patients effective and minimally invasive treatment options for a wide range of medical conditions.

[global-research-report]

Key Players and Competitive Landscape in the U.S. Ostomy Accessories Market

The U.S. ostomy care and accessories market size was valued at USD 543.68 million in 2023 and is expected to grow at a CAGR of 4.0% from 2024 to 2030. The ostomy care and accessories market is driven by several factors, such as increasing initiatives to raise ostomy awareness, technological advancements, increasing prevalence of bladder cancer, rise in geriatric population, & increasing risk of colorectal cancer.

U.S. market for incontinence and ostomy care products is primarily driven by the increasing prevalence of diverticular disease and colorectal cancer. In addition, the growing development in the medical devices market is expected to contribute to market growth. According to Johns Hopkins University, around 200,000 procedures for Benign Prostatic Hyperplasia (BPH) are conducted in the U.S. annually. Hence, the increasing number of BPH-related surgical procedures and rising cases of bladder cancer are expected to boost market growth. The U.S. ostomy care and accessories market accounted for 15% of the global nerve repair and regeneration market in 2023.

U.S. Ostomy Care And Accessories Market Segments Highlights

 

The bags segment held the largest market share of 90.19 % in 2023 owing to its wide applications. Ostomy bags are prosthetic medical devices used to collect stool or urine.

The colostomy segment held the largest market share of 46.04 % in 2023 owing to the growing geriatric population and rising cases of colorectal cancer. Colorectal cancer often requires surgical procedures such as colostomy on the affected portion of rectum or colon

The home care segment held the largest market share of 43.30 % in 2023 owing to the rising demand for home healthcare. 

The hospital segment is expected to register a considerable CAGR during the forecast period. The Segment growth can be attributed to the increasing government spending on developing smart hospitals. 

 

U.S. Ostomy Care And Accessories Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the U.S. ostomy care and accessories market report on the basis of product, application, and end use:

Product Outlook (Revenue, USD Million, 2018 - 2030)

Bags

One Piece

Two Piece

Accessories

Seals/Barrier Rings

Pouch Cover

Pouch Closures

Stoma Caps/Hat

Others

Application Outlook (Revenue, USD Million, 2018 - 2030)

Colostomy

Ileostomy

Urostomy

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Home Care Settings

Hospitals

Others

Order a free sample PDF of the U.S. Ostomy Care And Accessories Market Intelligence Study, published by Grand View Research.

[healthcaremarketanalysis]

Leading Urology Devices Manufacturers Driving Innovation in Urological Care

Urology devices play a critical role in diagnosing and treating various urinary tract and male reproductive system conditions. From catheters and stents to advanced robotic surgery systems, these devices offer solutions that improve patient outcomes and enhance healthcare efficiency. With an aging population and the increasing prevalence of urological conditions such as kidney stones, prostate issues, and urinary incontinence, the demand for urology devices is on the rise. Leading manufacturers in the field are meeting this demand through innovation, quality, and a focus on patient-centric solutions.

Download PDF Brochure

Key Players in the Urology Devices Market

Boston Scientific Corporation

A global leader in medical technology, Boston Scientific offers a broad portfolio of urology devices, including products for stone management, prostate health, and bladder control. Their innovations, such as the LithoVue™ Single-Use Digital Flexible Ureteroscope, are transforming how healthcare professionals diagnose and treat urological conditions.

Medtronic

Known for its expertise in medical devices, Medtronic is a prominent player in the urology field with solutions addressing overactive bladder and benign prostatic hyperplasia (BPH). Their minimally invasive therapies, such as the InterStim™ system for bladder control, offer patients more effective, less invasive treatment options.

Coloplast

A major manufacturer of intimate healthcare products, Coloplast is renowned for its urology and continence care solutions. Their product line includes urinary catheters, penile implants, and male incontinence devices, which help patients manage urological conditions with greater dignity and comfort.

Cook Medical

Cook Medical provides a wide range of urological devices, with a strong focus on treating kidney stones, urinary tract obstructions, and bladder dysfunction. The company's flexible ureteroscopes and stent technologies are designed to support urologists in delivering precise, effective treatments.

Olympus Corporation

Olympus is a pioneer in endoscopy, including devices used in urological procedures. Their high-definition imaging systems and minimally invasive surgical tools help physicians perform complex procedures, such as transurethral resection and stone management, with greater accuracy and reduced recovery times.

Request Sample Pages

Technological Advancements in Urology Devices

The urology devices market is experiencing rapid growth due to several technological advancements, including:

Robotic-Assisted Surgery: Systems like the da Vinci Surgical System by Intuitive Surgical allow for more precise urological procedures, improving patient outcomes and reducing recovery time.

Single-Use Devices: The trend towards single-use devices, such as flexible ureteroscopes, eliminates the need for device sterilization, reducing infection risks and improving workflow in clinical settings.

Smart Catheters: These devices can monitor bladder activity and provide real-time data to healthcare professionals, ensuring better management of conditions such as urinary retention.

The Future of Urology Devices

As the prevalence of urological disorders continues to increase, manufacturers are focusing on developing innovative and cost-effective solutions. Companies are also investing in research and development to enhance the safety, efficiency, and comfort of their devices. Minimally invasive surgery, personalized treatments, and smart technologies are key areas where urology device manufacturers will likely continue to make strides.

Conclusion

The urology devices market is expanding rapidly, driven by technological advancements and the increasing prevalence of urological conditions. Manufacturers like Boston Scientific, Medtronic, Coloplast, and Cook Medical are at the forefront of innovation, offering a wide range of devices that improve patient care. As the demand for effective and minimally invasive urological treatments grows, these companies are well-positioned to lead the industry in the coming years.

Content Source:

[metatechinsights]

Urinary Catheters Market Size and Forecast 2025-2035

The urinary catheters market is experiencing steady growth, with an expected market size of USD 2.3 billion in 2024, projected to reach USD 3.5 billion by 2035, growing at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2035. Urinary catheters are medical devices used for draining urine from the bladder when a patient is unable to do so naturally. The increasing prevalence of conditions such as urinary incontinence, bladder dysfunction, and post-surgical recovery is driving the demand for urinary catheters across the globe.

Market Drivers

Rising Prevalence of Urinary Disorders One of the primary factors driving the growth of the urinary catheters market is the rising prevalence of urinary disorders, including urinary retention, incontinence, and benign prostatic hyperplasia (BPH). These conditions are more common in the elderly population, leading to a growing need for catheterization in healthcare settings.

Technological Advancements in Catheter Design Advances in catheter technology, such as the development of antimicrobial-coated catheters, have helped reduce complications like urinary tract infections (UTIs), one of the major risks associated with catheterization. Manufacturers are also focusing on enhancing the comfort and safety of the devices, which is expanding their usage.

For more detailed insights and market trends, explore the full report here.

Increase in Surgical Procedures The growing number of surgical procedures worldwide is another key driver for the urinary catheter market. Post-surgical patients often require urinary catheters for short-term or long-term use, particularly those who have undergone surgeries affecting the pelvic region or urinary tract.

Rise in Geriatric Population The aging global population is a significant contributor to the market growth. Older individuals are more likely to experience conditions like incontinence and mobility issues, leading to an increased need for urinary catheters. The geriatric demographic is expected to drive the demand for both short-term and long-term catheterization solutions.

Regional Insights

North America: Dominates the urinary catheters market due to advanced healthcare systems, high awareness levels, and the rising incidence of chronic diseases.

Europe: Follows closely, with increasing healthcare spending and the growing elderly population contributing to market growth.

Asia Pacific: Expected to grow at the highest rate, driven by the rising healthcare infrastructure and awareness of medical devices.

Challenges and Opportunities Although the market is growing, challenges such as catheter-associated urinary tract infections (CAUTIs) and high treatment costs remain. However, opportunities lie in the development of next-generation catheters and expanding healthcare access in emerging economies.

In conclusion, the urinary catheters market is poised for growth, driven by technological advancements, increasing surgical procedures, and the aging population. Innovations in catheter design and expanding healthcare access will further fuel market expansion.

[pharmaceuticalsindustrynews]

Low-Cost and High Insurance Coverage Set to Make UroLift Procedure Most Popular Benign Prostatic Hyperplasia (BPH) Treatment Option in U.S. in Future

Benign Prostatic Hyperplasia (BPH) is a medical condition in which the prostate gland becomes enlarged. The enlargement of the prostate gland causes urinary tract problems by blocking the flow of urine out of the body. This happens because the prostate gland surrounds the urethra, which is the tube that carries the urine from the urinary bladder to out of the body, and so, the enlargement of the gland squeezes or blocks the urethra, causing discomfort and problems while urinating. 

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/us-bph-procedures/report-sample

This condition is common in geriatric men, so much so, that almost half of all men in the age bracket 51—60 years suffer from it. As per many studies and reports, up to 90% of all men over the age of 80 years all over the world suffer from benign prostatic hyperplasia. This disease is commonly treated via medications, laser-based treatment, transurethral resection of the prostate (TURP), and various other energy-based treatments such as prostate artery embolization and implants.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/market-analysis/us-bph-procedures/report-sample

Out of the surgical, laser-based, and UroLift procedures, the requirement for UroLift treatment procedures is predicted to rise rapidly in the U.S. in the forthcoming years. The main factors responsible for the growing popularity of these treatment procedures are the increasing aging population, lower-costs of the procedure in comparison to the other energy-based procedures, and increasing provision of insurance coverage for this procedure by many insurance companies in the country.

Out of these, the demand for green light laser-based procedures was observed to be significantly high in the U.S. during the last few years. According to many experts, the main factor responsible for the large-scale adoption of green light laser-based procedures was the fact that these procedures allow faster recovery and cause far lesser short-term side effects in comparison to the other laser-based procedures. Moreover, these procedures significantly improve the comfort level experienced by patients while urinating.

[healthcare-domain]

Prostate Health Market Size, Share | 2022 – 2026 | MarketsandMarkets

The global prostate health market is projected to reach $48.9 billion by 2026, Provides crucial industry insights that will help your business grow. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, increase in prevalence of prostate cancer, surge in demand for hormone therapy drugs, emerging therapies for prostate cancer and increasing incidence of prostatitis.

The prostate health market witnessed a loss of business, and the trend continued till late December 2020. Unfavorable changes in regulations and guidelines are hindering the growth of this industry.

Major regulatory authorities across the globe (such as CDC, WHO, MHRA, TGA, and EMA) have identified that cancer patients are at greater risk of contracting the coronavirus infection than healthy adults. Thus, prostate care, diagnostic tests, and surgical treatments in hospitals are severely restricted or postponed at hospitals and cancer care centers. This is expected to cause disturbances in the prostate health market. Owing to the factors above, caregivers and hospitals are anticipated to witness delays in elective surgeries and screening procedures.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107055093

However, the market has gradually increased from the second half of 2020 due to the rise in the number of oncology appointments, prostate cancer therapies among others resulting from efforts to clear backlogs and new cases and fully re-opened healthcare services.

Data from the Health Insurance Review and Assessment (HIRA) agency in 2018 showed that nearly 7,600,000 patients were diagnosed with BPH in 2010, which increased by ~1.2 million in 2017. This represents an annual growth of about 7% and a total increase of 58% from 2010.

Obesity and Benign Prostatic Hyperplasia (BPH) are closely associated. According to the Journal of Global Health Reports published in 2019, nearly 37.1% of men aged 60 years and older in the US were classified as obese. Studies reveal that the prevalence of obesity generally increases among men with progressing age, leading to BPH. Obesity leads to several mechanisms such as enhanced sympathetic nervous activity, altered endocrine status, increased intra-abdominal pressure, increased inflammation process, and oxidative stress, which are favorable conditions for the development of BPH.

The prevalence of prostate cancer rises with an increase in age. Prostate cancer is the most common category of cancer among men. According to the American Cancer Society’s estimates for prostate cancer in 2021, about 248,530 new cases and 34,130 deaths occurred in 2020 due to prostate cancer in the US.

The prostate cancer phase III pipeline is diverse and comprises molecules in approved drug classes as well as drugs with novel mechanisms of action, including radioligands targeted to prostate-specific membrane antigen (PSMA), kinase inhibitors, and immune checkpoint inhibitors.

[isucheta]

Increase in Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors to Drive Global Benign Prostatic Hyperplasic Devices Market

According to our new research study on "Benign Prostatic Hyperplasic Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Procedure Type, End User, and Geography" the market is expected to grow from US$ 2,078.78 million in 2021 to US$ 3,467.31 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the benign prostatic hyperplasic devices market is primarily attributed to the rise in the prevalence of benign prostatic hyperplasia among men, increasing risk factors, and a rise in investments, funds, and grants for research in BPH treatment. However, less awareness about prostate health among men is hampering the market's growth to a certain extent.

Get Sample PDF at:- https://www.theinsightpartners.com/sample/TIPRE00025704/

Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a non-cancerous prostate condition that is not usually fatal. As it is  benign, the condition does not involve metastasis to other body parts. BPH is not associated with the risk of prostate cancer; moreover, unless it manifests symptoms, BPH is not considered a health issue. Almost all men are likely to have some prostate growth by age 70. Aging, abdominal obesity, and lack of physical exercise raise the risk of developing BPH.

The companies engaging in the benign prostatic hyperplasic devices market witnessed a negative impact on their services in early 2020 due to the temporary shutdown of their manufacturing sites caused by the COVID-19 pandemic. Most service providers prioritized actions to help the critical work of consumers included in COVID-19, such as giving a range of high-quality COVID-19-related research tools, reassigning R&D resources for producing essential products for COVID-19, expanding the supply chain, providing flexibility to support expanded demand for enduring products applied for COVID-19 research, and entering into discussions and collaborations across the UK, the US, and China concentrated on SARS-CoV-2 diagnostics, drugs, and vaccines development. Surgical procedures such as TURP, HoLEP, ThuLEP, and PVP were postponed because of COVID-19. According to a recent study, nearly 2.5 million urological benign surgeries were estimated to be canceled during the peak of disruption by COVID-19. However, the number of alternative surgical procedures increased. For instance, laser treatment can be adopted by additional surgery centers and other outpatient facilities not focused on COVID-19 patients.

The report segments the benign prostatic hyperplasic devices market as follows:

Based on product, the benign prostatic hyperplasic devices market is segmented into resectoscopes, urology laser, radiofrequency ablation devices, prostatic stents, and implants. Based on procedure type, the market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. By geography, the benign prostatic hyperplasic devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused toward market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, product and service, radioisotope types, application and end user, which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us

If you have any queries about this report or if you would like further information, please contact us:

North America: +1 646 491 9876

Asia Pacific: +91 20 6727 8686

Email: sales@theinsightpartners.com

[blog-site-for-market-research]

Urology Devices Market Outlook, Industry Trends and Global Forecasts, 2023-2032

Market Scope

The urological devices market was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.

Growth Drivers and Challenges

Notable rise in the number of patients suffering from diabetes and high blood pressure (hypertension) has fostered the demand for advanced urology devices in recent years. These diseases are known for causing kidney failure. The American Kidney Fund’s recent studies show that nearly 40.4% of the overall kidney failure cases worldwide are caused by diabetes, while 30% is the result of high blood pressure. Cases of diabetes and hypertension have been surging exponentially in developing countries across Middle East and Asia Pacific, considering the prevalence of stressful and hectic lifestyle and the burgeoning elderly populace.

Another growth rendering factor can be the expanding geriatric population prone to kidney and urinary disorders. The demand for urology devices is further elevated by the mounting demand for minimally invasive procedures and surge in technical advances. Canada as well as the United States (US) are experiencing substantial rise in the number of people affected by chronic kidney and urinary disorders in conjunction with the growing prevalence of a sedentary lifestyle. On top of this, large-scale funds by governments for improving the healthcare infrastructure would also have an incredible impact on the global market.

Market Segmentation

The MRFR study has outlined various aspects of the urology devices market report for enhanced understanding, shedding light on major segments like types, applications, technology, and end users.

Different types of urology devices available in the industry are endoscopy devices, urinary incontinence & pelvic organ prolapsed devices, urinary stone treatment devices, benign prostatic hyperplasia treatment devices, dialysis equipment, and more.

Urology devices’ top applications are Prostate Cancer, Urinary Incontinence, Urinary Stones, as well as Benign Prostatic Hyperplasia. Urinary stones occur in 1 in every 20 individuals, with the major reasons being diabetes, high blood pressure, and history of kidney failure. As a result, urology devices market outlook are witnessing enormous demand for treating urinary stones, cases of which have been escalating rapidly worldwide.

Technology-wise, the segments are minimally invasive surgery, robotic surgery, and more.  

End-users listed are ambulatory services, hospitals, and more.

Regional Analysis

The urology devices industry has been regionally considered for APAC/Asia Pacific, MEA/Middle East & Africa, the Americas, and Europe.

America maintains its winning streak and will continue to do so throughout the evaluation timeframe, thanks to the escalating cases of kidney stones, traumatic injury, prostate cancer, and others. The American Urological Association Foundation confirms that benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections, and kidney and ureteral stones are the top urological ailments occurring in the region. Surge in lifestyle-based health issues, significant healthcare spending, and a well-developed healthcare system present in both Canada and the US also add to the regional market value. Favorable reimbursement structure also add to the market worth. Not only clinics and hospitals, but urology devices are increasingly being used in the domestic sector as well, as the rising number of geriatric patients prefer at-home settings.

Asia Pacific could be the fastest progressing market in the next few years, on account of the booming population with significant unmet medical needs and the surge in economic standards. Mounting cases of Benign Prostatic Hyperplasia (BPH) as well as Urinary Tract Infection (UTI) also raises the demand for urology devices. With the rising focus on replacing and upgrading the existing healthcare infrastructure, urology devices would note higher demand in the following years. Besides, majority of the players in the region are spending considerably on exhaustive research and development of the latest types of urology devices. Urology device manufacturers are also indulging in mergers and acquisitions to enhance individual as well as cumulative industry growth.

Top Companies

The top urology devices manufacturers in the market are C. R. Bard Inc. (US), Boston Scientific Corporation (US), Stryker (US), Olympus Corporation (Japan), HealthTronics, Inc (US), KARL STORZ GmbH & Co. KG (Germany), NIKKISO CO. LTD (Japan), Medtronic (US), Dornier MedTech (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Cook (US), and many more.

These contenders expend huge amounts on research and development (R&D) for product innovation as well as new launches, which helps them gain a higher share in the worldwide industry. They also use strategies such as acquisitions, FDA approvals, collaborations, expansions, and joint ventures, among others.

For instance, in May 2021, Olympus Corporation acquired Medi-Tate Ltd., an Israeli medical device firm. The acquisition is projected to bolster Olympus’s position in the urological devices market, also bolstering its product offering for the treatment of benign prostatic hyperplasia (BPH) treatment.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com

[marketresearchindia]

Global Machine Vision In Mobile Devices Market Growth Is Propelled By Growing Investments In R&D Activities: Ken Research

Buy Now

A urinary catheter is a hollow, incompletely flexible tube, which is utilized to drain urine when an individual is powerless to do it naturally. The urinary self-catheter industry is projected to experience proficient growth during the review period, due to increment in requirement for hydrophilic intermittent catheter across geographies. Growth in number of prostate surgeries; augment in prevalence of benign prostate hyperplasia, urinary incontinence, and spinal cord injuries; augment in geriatric population, and employment of favourable reimbursement policies for utilization of intermittent catheter further boost the growth of urinary self-catheters market.  

According to the report analysis, ‘Global Urinary Self Catheter Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027’ states that B. Braun, Bard Medical, Coloplast, Medtronic, Med Tech GA, Hollister, Teleflex, ASID BONZ GmbH, ConvaTec, Cook Medical and many more are the foremost companies which presently working in the global urinary self catheter market more proficiently for keep maintaining the governing position, registering the great value of market share, obtaining the competitive edge, leading the highest market growth and generating the highest percentage of revenue by analysing the strategies and policies of government as well as contenders, spreading the awareness connected to the applications and advantages of urinary self catheter, decreasing the associated prices of such, delivering the better customer satisfaction, increasing the features and benefits of urinary self catheter, improving the qualitative and quantitative measures of such, implementing the policies of profit making and strategies of expansion, and analysing the strategies and policies of government as well as contenders.

The urinary self catheters market is predicted to observe lucrative growth opportunities over the forecast duration, owing to speedy healthcare improvements, augment in geriatric population, and enhanced healthcare infrastructure. Technological innovations and favorable reimbursement policies in the healthcare sector assist the market expansion. Bladder catheterization is the most commonly executed process in hospitals, which propels the urinary catheters market. The effective growth in prevalence of prostate cancers and surging prostate functions in hospitals requirement for urinary catheters on a constant basis.

Request For Sample Report-https://kenresearch.com/sample-report.php?Frmdetails=NDQ0OTAw

North America shows profitable growth opportunities in the urinary self-catheters market due to growing geriatric population, innovations in the healthcare industry, and augmenting the number of surgical procedures. Advancements in healthcare facilities and growing investments in R&D activities in urinary catheters are propelling the expansion of the global market. North America is registering the urinary self catheters market due to its speedily developing healthcare infrastructure and awareness of urinary catheters. Market contributors from North America are aiming on adopting several strategies to strengthen their market existence.

Also, regulatory policies in Asia Pacific are more adaptive and business-friendly than those in developed regions. This, along with the growing competition in mature markets, has induced foremost players in the urinary self catheters market to aim on emerging economies. Therefore, it is predicted that during the near period the market of urinary self catheter will augment more proficiently over the assess period.

For More Details-

Global Urinary Self Catheter Market Research Report

Related Post-

2021-2027 Global and Regional Infusion Pump Industry Status and Prospects Professional Market Research Report Standard Version

2021-2027 Global and Regional ECHO Cardiography Industry Status and Prospects Professional Market Research Report Standard Version

Follow Us

LinkedIn | Instagram | Facebook | Twitter | YouTube

Contact Us:-

Ken Research                                                                                          

Ankur Gupta, Head Marketing & Communications

support@kenresearch.com

+91-9015378249